Matches in Nanopublications for { ?s ?p "[In the current study using fluorescence in situ hybridization (FISH), we identified the TMPRSS2:ERG rearrangements in 49.2% of 118 primary prostate cancers and 41.2% of 18 hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP170513.RAldSOySpI_xys1vSJ5jCeAMVvjrtMFZa8R-LMZVjRrqw130_assertion description "[In the current study using fluorescence in situ hybridization (FISH), we identified the TMPRSS2:ERG rearrangements in 49.2% of 118 primary prostate cancers and 41.2% of 18 hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170513.RAldSOySpI_xys1vSJ5jCeAMVvjrtMFZa8R-LMZVjRrqw130_provenance.
- NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_assertion description "[In the current study using fluorescence in situ hybridization (FISH), we identified the TMPRSS2:ERG rearrangements in 49.2% of 118 primary prostate cancers and 41.2% of 18 hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_provenance.
- NP614386.RAH7anZgcNwTf0jzn7KkrE2AwExpJgU_Rwhh_ygs9UWdY130_assertion description "[In the current study using fluorescence in situ hybridization (FISH), we identified the TMPRSS2:ERG rearrangements in 49.2% of 118 primary prostate cancers and 41.2% of 18 hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614386.RAH7anZgcNwTf0jzn7KkrE2AwExpJgU_Rwhh_ygs9UWdY130_provenance.